Elazer Edelman, M.D., Ph.D.
Dr. Edelman is the Thomas D. and Virginia W. Cabot Professor of Health Sciences and Technology at MIT, Professor of Medicine at Harvard Medical School and a coronary care unit cardiologist at the Brigham and Women’s Hospital in Boston. He and his laboratory have pioneered basic findings in vascular biology and the development and assessment of biotechnology. Dr. Edelman directs the Harvard-MIT Biomedical Engineering Center dedicated to applying the rigors of the physical sciences to elucidate fundamental biological processes and mechanisms of disease. He received a BS degree in Bioelectrical Engineering and in Applied Biology from MIT, an MS in Electrical Engineering and Computer Science from MIT, a degree in medicine from Harvard Medical School and a Ph.D. in Medical Engineering and Medical Physics from MIT.
Laird Forrest, Ph.D.
Dr. Forrest is an Associate Professor in the Department of Pharmaceutical Chemistry at the University of Kansas. His research focus is on the development of nanocarrier materials that can confine chemotherapeutics to the region of early and middle-stage metastatic disease. Dr. Forrest received his Ph.D. in Chemical and Biomolecular Engineering from the University of Illinois. He did postdoctoral work in Pharmaceutical Sciences at the University of Wisconsin.
Mr. Piwczyk brings significant knowhow and expertise in several important industrial markets being addressed by Exogenesis. Mr. Piwczyk brings extensive research and manufacturing experience in the fields of advanced lithography and electron beam lithography from his work with Nortel and Varian-Extrion Corporation. He brings expertise in the manufacturing of reactive ion etch, plasma etch, sputter deposition and ultra-precision metrology systems for the semiconductor industry. He has also worked extensively in the manufacture of photovoltaic solar cells using high power lasers with Schott Solar and IPG Photonics. Mr. Piwczyk received his BSc in Chemistry from California Polytechnic State University.
Laurence Tarrant, Ph.D.
Dr. Tarrant has extensive experience in commercializing medical technologies. As President of ITMA Ltd. he fostered technology transfer between Japan and the United States, resulting in the creation of several biomedical start-up firms. As a consultant, Dr. Tarrant developed biomedical products for leading medical device companies such as Stryker Corp. and NobelPharma. He currently serves as Chairman and Chief Scientific Officer of Histogenics Corp. He has served as Provost, Vice President for Academic Affairs and Professor of Biology at Clark University. He also held positions at New York University, State University of New York and the National Science Foundation. Dr. Tarrant received his Ph.D. in Developmental Genetics from the University of California at Berkeley. He did postdoctoral work in Developmental Biochemistry with CH Waddington and Max Birnstiel at the University of Edinburgh.
Isao Yamada, Ph.D.
Dr. Yamada is Professor Emeritus at Kyoto University and a Visiting Professor at the Graduate School of Engineering at the University of Hyogo in Japan. The principal areas of his research interest over the past 40 years have spanned investigations of the basic physics of ion beam materials processing, including very low energy ion-solid interactions. His most significant contribution is the development of gas cluster ion beam processing which is now being introduced as a fundamental tool in the emerging new field of nano-scale processing. Recently, he has conducted two large scale Japanese government projects in order to promote gas cluster ion beam technology for industrial applications. He received his Ph.D. degree in Electrical Engineering from Kyoto University.